Related Experiment Video
Updated: Jun 19, 2026

Protocol for Isolating the Mouse Circle of Willis
Published on: October 22, 2016
[Cerebral vessel disease and inflammatory process]
1Department of Neurology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita-shi, Osaka 565-0871, Japan.
Insights
Inflammation drives atherosclerosis, increasing risks for heart attack and stroke. Targeting inflammation may prevent cerebral infarction.
Area of Science:
- Cardiovascular Science
- Neuroscience
- Immunology
Context:
- Atherosclerosis, characterized by atheromatous plaque, is a significant risk factor for cerebrovascular events.
- Inflammation is a key driver in the development, progression, and rupture of atherosclerotic plaques.
- Blood inflammatory markers, like high-sensitivity C-reactive protein (hs-CRP), are linked to myocardial and cerebral infarction.
Purpose:
- To explore the role of inflammation in atheromatous plaque development and cerebrovascular disease.
- To investigate the association between blood inflammatory markers, carotid plaque characteristics, and cerebral small vessel disease.
- To evaluate the potential of anti-inflammatory therapies for cerebral infarction prevention.
Summary:
- Inflammation is central to atheromatous plaque pathogenesis, influencing its progression and rupture.
- Elevated blood inflammatory markers, including hs-CRP, correlate with increased risk of myocardial infarction and cerebral infarction.
- Inflammatory cells within carotid plaques express various pro-inflammatory mediators, impacting plaque stability and echogenicity.
- Blood inflammatory marker levels are associated with carotid plaque progression, echogenicity, and the severity of intracranial arterial diseases, including silent infarction and white matter lesions.
Impact:
- Understanding inflammation's role in atherosclerosis can lead to novel diagnostic markers for stroke risk.
- Identifying inflammatory pathways involved in plaque rupture offers targets for therapeutic interventions.
- Anti-inflammatory strategies hold promise for both primary and secondary prevention of cerebral infarction, potentially reducing stroke burden.
Abstract:
Inflammation plays an important role in the development, progression, and rupture of the atheromatous plaque. Blood inflammatory markers such as high sensitivity CRP (hs-CRP) can predict not only myocardial infarction but also cerebral infarction in the later life. Recent histological examinations showed that plaque rupture causes vascular accident in the brain in both extracranial and intracranial arteries. Inflammatory cells in the carotid atheromatous plaque are known to express proinflammatory cytokines, chemokines, and inflammatory enzymes. Levels of inflammatory markers in the blood are associated with plaque progression and echogenicity in the carotid artery and severity and progression of intracranial larger artery and small cerebral vessel diseases such as silent infarction and white matter lesions. Anti-inflammatory treatment for blood vessel might be a promising strategy for the primary and secondary prevention for cerebral infarction.
Related Concept Videos
Cerebral Edema ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Bacterial Meningitis II: Pathophysiology
Cerebral Edema l: Introduction
Ischemic Stroke ll: Pathophysiology
